Bellevue Life Sciences Acquisition Overview

Bellevue Life Sciences Acquisition Profit Margin

Profitability ratio analysis for BLAC.

Quarterly Profit Margin

-716.27%

↑ 52.14% YoY

As of Mar 2026

Annual Profit Margin (TTM)

301.52%

↑ 116.70% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin